comparemela.com

Il 36 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Spesolimab for Treatment of Generalized Pustular Psoriasis (GPP) Flares

Dermatologists Drs Tina Bhutani and Scott Boswell discuss use of spesolimab to treat generalized pustular psoriasis (GPP) flares.

Tina bhutaniJ scott boswellKanya oulGeneralized pustular psoriasisInflammatory diseaseGpp flaresSystemic diseaseIl 36Subcutaneous injectionMaintenance therapy

Use of Biologics in Rare Dermatologic Disorders

Experts discuss the use of biologics in the treatment of rare dermatologic disorders.

Identifying rare dermatologic disordersCritical care settingRare dermatologicRare dermatological disordersIl 36Il 36 inhibitorsIl 17 inhibitorsTnf alpha inhibitors

Spesolimab meets primary and key secondary endpoint for prevention of generalized pustular psoriasis flares

EFFISAYIL™ 2 met its primary and key secondary endpoint, demonstrating that spesolimab, an anti-interleukin-36 receptor antibody, can prevent flares in adolescents and adults with generalized pustular psoriasis (GPP) up to 48 weeks.1,2

Rheinland pfalzLaura lessenichCarinne brouillonEuropean unionCorporate communicationsBoehringer ingelheimManaging directorsHuman pharmaMainland chinaMedia contactFfisayil 2Generalized pustular psoriasisClinical trialsCarinne brouillonHuman pharmaRare skin disease

vimarsana © 2020. All Rights Reserved.